Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...
Vitamin D also helps clear beta amyloid, a protein that plays a role in Alzheimer’s disease, Merrill points out. This is “the ...
According to Alzheimer's Society, almost one million people are living with dementia in the UK - this is expected to increase ...
The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS. Regulators are due to ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
There's still so much we don't know about Alzheimer's disease, but the link between poor sleep and worsening disease is one ...
2024 saw a new drug enter the dementia landscape, as the U.S. Food and Drug Administration (FDA) approved Kisunla (donanemab) ...
A new pill that ‘slows down Alzheimer's ' is being considered for use in the NHS. Developed by a small British firm in ...
State Sen. Catherine Blakespear wants to engage stakeholder groups to discuss possible changes to the law, but she faces ...
In this prognostic study, with the use of a statistical modeling approach, the Florey Dementia Index was developed and validated to predict the onset age of mild cognitive impairment and Alzheimer ...
The symptoms of alcohol-related dementia can vary, but they usually involve changes in how a person thinks and acts. Some ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback